Revium Rx (RVRC) Payables (2024 - 2025)
Revium Rx (RVRC) reported Payables of $738000.0 for Q4 2025, up 416.08% on a YoY basis from $143000.0 in Q4 2024, and up 416.08% sequentially from $143000.0 in Q4 2024.
Revium Rx (RVRC) Payables (2024 - 2025) Analysis & Trends
Revium Rx (RVRC) has 2 years of Payables data on file, last reported at $738000.0 in Q4 2025.
- For the quarter ending Q4 2025, Payables rose 416.08% year-over-year to $738000.0; the trailing twelve-month figure through Dec 2025 stood at $738000.0 (up 416.08% YoY), and the FY2025 full-year result was $738000.0, up 416.08% from the prior year.
- Payables climbed to $738000.0 in Q4 2025, from $143000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $738000.0 in Q4 2025 to a low of $143000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.06 Bn | 24.75 Bn | 662.02 Mn | 40.66 Mn |
| 2 | BrightSpring Health Services | 14.64 Bn | 13.74 Bn | 482.22 Mn | 1.09 Bn |
| 3 | Healthequity | 8.29 Bn | 8.02 Bn | 256.31 Mn | 14.22 Mn |
| 4 | Hinge Health | 5.97 Bn | 5.66 Bn | 154.23 Mn | 69.48 Mn |
| 5 | 10x Genomics | 5.95 Bn | 5.41 Bn | 106.18 Mn | 17.43 Mn |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | 163.00 Mn |
| 7 | Waystar Holding | 4.48 Bn | 4.42 Bn | 216.84 Mn | 58.80 Mn |
| 8 | Doximity | 3.95 Bn | 3.20 Bn | 125.97 Mn | 4.01 Mn |
| 9 | Privia Health | 3.14 Bn | 2.72 Bn | - | 80.56 Mn |
| 10 | Revium Rx | 101.42 Mn | 98.71 Mn | - | 738,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 738,000.00 |
| Dec 31, 2024 | 143,000.00 |